The U.S. Food and Drug Administration has approved Johnson & Johnson’s drug Invokana, which will be used to treat type 2 diabetes.
According to the New York Times, Invokana is the first of a new class of diabetes medication. It causes blood sugar to be excreted in the urine, as opposed to many other drugs on the market that work by affecting the supply or use of insulin.
Last year, the FDA ...
continue reading...
A number of prominent nutritionists have reiterated a warning about a potential link between red meat consumption and Type 2 diabetes, the Los Angeles Times reports.
Although diabetes is manageable, the Mayo Clinic says it can eventually cause disabling or even life-threatening complications.
And a growing body of evidence links some diabetes treatments – including the drugs Byetta and Januvia — to a potentially deadly inflammation of the pancreas called pancreatitis, and ...
continue reading...
Pancreatic Cancer UK, a charity group based in the United Kingdom, has joined the American Diabetes Association in calling for companies to release information about a potential link between some diabetes medication and pancreatic cancer.
Pressure on the companies is intensifying after Channel 4 Dispatches and the medical journal BMJ reported the results of a joint investigation, BMJ says.
That investigation added to a growing body of evidence suggesting a potential link ...
continue reading...
An investigation in the medical journal BMJ faults the U.S. Food and Drug Administration for its tepid response to reports that diabetes drugs including Byetta and Januvia may be linked to pancreatitis and pancreatic cancer.
Both the FDA and the European Medicines Agency are conducting investigations into that class of drugs, called incretin mimetics, the story says. And both agencies have confirmed that their own analyses show increased reporting or signals ...
continue reading...
In the course of an investigation about the class of diabetes drugs that includes Byetta and Januvia, the medical journal BMJ uncovered evidence suggesting that manufacturers tried to repress evidence linking the drugs to serious health problems.
A growing body of evidence has linked incretin therapies such as Byetta and Januvia to both pancreatitis (a potentially deadly inflammation of the pancreas) and pancreatic cancer. Byetta has also been linked to thyroid ...
continue reading...
According to a story in MedPage Today, the American Diabetes Association is calling for makers of diabetes drugs such as Byetta and Januvia, classified as “incretin therapies,” to release all of the data on their drugs for a review.
The ADA’s demands come as a growing body of evidence links drugs such as Byetta and Januvia to a potentially deadly inflammation of the pancreas called pancreatitis, and to pancreatic cancer. Byetta ...
continue reading...
